We serve Chemical Name:5-Bromo-1,2-dihydroacenaphthylene CAS:2051-98-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Bromo-1,2-dihydroacenaphthylene
CAS.NO:2051-98-1
Synonyms:Acenaphthylene, 5-bromo-1,2-dihydro-;5-bromoacenaphthene;5-acenaphthyl bromide;4-bromoacenaphthene;EINECS 218-138-7;1-bromoacenaphthene;ACENAPHTHYLENE,5-BROMO-1,2-DIHYDRO;5-Bromo-1,2-dihydroacenaphthylene;5-bromoacenaphtene;Acenaphthene,5-bromo;MFCD00003809
Molecular Formula:C12H9Br
Molecular Weight:233.104
HS Code:2903999090
Physical and Chemical Properties:
Melting point:54-56 °C(lit.)
Boiling point:335.0±0.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.715
PSA:
Exact Mass:231.988754
LogP:4.96
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Acenaphthylene, 5-bromo-1,2-dihydro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00003809 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromoacenaphthene Use and application,1-bromoacenaphthene technical grade,usp/ep/jp grade.
Related News: The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 5-Bromo-1,2-dihydroacenaphthylene manufacturer The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 5-Bromo-1,2-dihydroacenaphthylene supplier The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 5-Bromo-1,2-dihydroacenaphthylene vendor In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. 5-Bromo-1,2-dihydroacenaphthylene factory From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.
